AI-native electronic batch records integrated within Sapio GMP LIMS, featuring no-code template configuration, 21 CFR Part 11 compliance, and immutable audit trails for pharmaceutical GMP manufacturing.
Sapio Electronic Batch Records (EBR), launched in October 2024, is an integrated module within Sapio's GMP LIMS solution designed to track every aspect of batch manufacturing processes while ensuring batch-level quality control and traceability. The platform unifies LIMS, ELaiN (AI-native electronic lab notebook), and Scientific Data Cloud (SDMS) on a shared native AI foundation, enabling pharmaceutical and biotech manufacturers to manage batch records alongside laboratory workflows in a single system.
The no-code template configuration enables scientists and quality personnel to create and modify batch records without programming expertise, supporting flexible workflow adjustments based on product, process, or regional regulatory requirements. The system features an immutable audit log tracking every action with timestamped electronic signatures, which the vendor states meets 21 CFR Part 11 and EU Annex 11 requirements. End-to-end batch process automation extends from raw material management through final quality control with integrated deviation management and corrective action documentation.
The platform includes agentic AI co-scientist capabilities built across all functions, integration with environmental monitoring for continuous tracking of critical parameters (temperature, humidity) with automated excursion alerts, and real-time dynamic dashboards providing immediate production oversight. Material traceability features barcode scanning, weight monitoring, and equipment calibration validation with integrated maintenance scheduling.
Sapio serves pharmaceutical, biotechnology, clinical diagnostics, and contract research organizations (CROs/CDMOs) throughout the drug lifecycle from discovery through manufacturing. Notable customers include Oxford Biomedica, Genentech, BioNTech, Charles River, PTC Therapeutics, and Caris Life Sciences. The company is SOC 2 Type II certified (2023), ISO 27001 certified, and holds HDS certification for French healthcare data hosting.
Pharmaceutical Edition
Sapio Sciences markets specialised GMP-compliant solutions for pharmaceutical and biotech manufacturing: Sapio GMP LIMS for quality control, manufacturing, and bioprocessing; Sapio EBR for electronic batch records, added October 2024; and templates for clinical or molecular diagnostics, bioanalytical studies, and stability testing. The vendor describes the platform as serving "pharmaceutical, biotechnology, clinical diagnostics, and contract research organizations," with GxP validation stated for regulated environments.
Core Capabilities
FDA & GxP Compliance
International Standards
Security Certifications
Data Integrity & Validation
Sapio Sciences delivers an AI-native lab informatics platform as a cloud-based SaaS solution, uniting LIMS, ELaiN (electronic lab notebook), and Scientific Data Cloud (SDMS) on a shared AI foundation. The platform operates as a living knowledge graph with full searchability and contextualization of scientific data across all modules.
The no-code configurability allows scientists to define batch workflows without programming, using visual configuration tools for template creation and modification. The system provides barcode scanning integration for material tracking, instrument connectivity for automated result capture, and environmental monitoring system integration for real-time parameter tracking. Built-in molecular biology tools include CRISPR editing, plasmid design, flow cytometry analysis, and 3D plating capabilities. The architecture enables real-time collaboration across teams with reusable scientific objects and unified data management. Integration capabilities support existing enterprise systems including ERP, MES, and quality management platforms.
Pricing is not publicly disclosed: no specific tiers, per-user costs, or annual licence fees appear on the website. Sapio Sciences operates on a SaaS subscription-based pricing model, serving pharmaceutical, biotech, clinical diagnostics, and contract research organisations.
Demos of the integrated LIMS/ELN/SDMS/EBR platform and custom quotes are available, based on organisational size, module selection (LIMS, ELaiN, SDMS, EBR), deployment scope, and number of users. The vendor states its no/low-code functionality reduces total cost of ownership.
Sapio Sciences provides Sapio Consulting services for implementation, including deployment support, workflow configuration, and validation assistance. Out-of-the-box templates target specialised implementations for clinical diagnostics, GMP manufacturing, bioanalytical studies, and bioprocessing; the vendor states these reduce customisation requirements and accelerate time-to-value.
The no-code architecture enables modifications without extensive IT intervention, allowing quality and manufacturing teams to adjust batch templates and workflows as regulatory requirements or processes evolve. User testimonials highlight ease of implementation, with subject matter experts indicating Sapio "could be easily implemented within their companies," appreciating the clear user interface and create rule function for workflow dependencies.
Anonymous feedback from pharmaceutical professionals using this solution
4.3 out of 5
Based on 39 verified reviews
What Users Like
Users highly value Sapio's customization capabilities and configuration flexibility, praising the no/low-code functionality that enables scientists to modify workflows without programming. The intuitive searching function and clear user interface simplify sample and experiment tracking. The quality and responsiveness of the support team is consistently cited as a key reason for successful implementation, with users appreciating the friendly, experienced approach and willingness to work collaboratively with clients. The out-of-the-box features reduce implementation complexity, with subject matter experts indicating the platform "could be easily implemented within their companies." The create rule function for workflow dependencies is particularly valued for building complex laboratory processes. Users appreciate the unified platform approach integrating LIMS, ELN, and SDMS capabilities, eliminating data silos.
What Users Dislike
Independent, Sapio-specific negative feedback is limited. Sapio's own analysis of common LIMS complaints, which may or may not describe Sapio EBR specifically, identifies complexity requiring extensive training for advanced features, occasional performance issues with large datasets, and a learning curve for configuring sophisticated workflows. Some users note that while the platform is highly configurable, achieving optimal configuration for complex laboratory processes may require significant upfront planning and validation work. The platform's comprehensive capabilities can feel overwhelming initially for users transitioning from simpler systems or paper-based processes.
Help the community
Share your experience with Sapio Electronic Batch Records anonymously. Your insights help pharmaceutical professionals make better software decisions.
Contribute Anonymous FeedbackPublicly disclosed pharmaceutical and biotech organizations
Jump to section